FDA Grants Conditional Approval for Spine System

Interventional Spine, Inc. announced that the U.S. Food and Drug Administration has approved the Company's investigational device exemption (IDE) application for its PercuDyn System for the treatment of degenerative disc disease (DDD).
StreetInsider.com